Hinge Health holder plans $39.1M stock sale

The notice also lists six prior Class A sales by the 10% stockholder between July 7 and August 10, 2026.

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) is the issuer named in a Form 144 notice by 10% stockholder Insight Venture Partners (Cayman) X, L.P., which lists 399,338 Class A shares for sale through Raymond James & Associates, Inc. The approximate sale date is September 30, 2026; the listed aggregate market value is $39,135,124. The notice lists 62,468,721 shares outstanding.

Key Figures

Shares listed for sale: 399,338 Class A shares Aggregate market value: $39,135,124 Shares outstanding: 62,468,721 shares +2 more

5 metrics

Shares listed for sale 399,338 Class A shares By Insight Venture Partners (Cayman) X, L.P.

Aggregate market value $39,135,124 For the shares listed for sale

Shares outstanding 62,468,721 shares Hinge Health, Inc.

Prior sale 100,195 Class A shares July 7, 2026

Prior sale 253,638 Class A shares August 10, 2026

Key Terms

10% Stockholder, Rule 144, Stock Conversion before IPO, Wired to portfolio company

4 terms

10% Stockholder regulatory

"10% Stockholder"

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Conversion before IPO financial

"Stock Conversion before IPO"

Wired to portfolio company financial

"Wired to portfolio company"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HNGE shares does Insight Venture Partners plan to sell?

The notice lists 399,338 Hinge Health Class A shares for sale by Insight Venture Partners (Cayman) X, L.P. through Raymond James & Associates, Inc., with an approximate sale date of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/30/2026 - 06:13 PM Accepted by SEC EDGAR 09/30/2026 - 06:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001710860
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Insight Venture Partners (Cayman) X, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Raymond James & Associates Inc. 880 Carillon Parkway St. Petersburg FL 33716	399338	39135124.00	62468721	09/30/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series B Preferred Stock	07/03/2018	Stock Conversion before IPO	Hinge Health, Inc.			4485644	07/03/2018	Wired to portfolio company

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Insight Venture Partners (Cayman) X, L.P 1114 Avenue of the Americas 36th floor New York NY 10036	Class A	07/07/2026	100195	9040224.13
Insight Venture Partners (Cayman) X, L.P 1114 Avenue of the Americas 36th floor New York NY 10036	Class A	07/09/2026	74325	6704070.41
nsight Venture Partners (Cayman) X, L.P 1114 Avenue of the Americas 36th floor New York NY 10036	Class A	07/13/2026	100074	9019389.41
nsight Venture Partners (Cayman) X, L.P 1114 Avenue of the Americas 36th floor New York NY 10036	Class A	07/14/2026	15980	1443633.20
Insight Venture Partners (Cayman) X, L.P 1114 Avenue of the Americas, New York NY 10036	Class A	08/07/2026	56401	5084708.07
Insight Venture Partners (Cayman) X, L.P 1114 Avenue of the Americas 36th floor New York NY 10036	Class A	08/10/2026	253638	23212290.30

144: Remarks and Signature

Remarks
Date of Notice	09/30/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Insight Venture Partners (Cayman) X,
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)